Immune-mediated thrombotic thrombocytopenic purpura
Synonyms: Acquired TTP | Acquired thrombotic thrombocytopenic purpura | Autoimmune thrombotic thrombocytopenic purpura | Thrombotic thrombocytopenic purpura due to anti-ADAMTS-13 antibodies | aTTP | iTTP
A rare non-hereditary thrombotic thrombocytopenic purpura (TTP) characterized by profound peripheral thrombocytopenia microangiopathic hemolytic anemia (MAHA) and single or multiple organ failure of variable severity.
Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.
Reference: Access aggregated data from Orphanet at Orphadata.
Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http: //www.orphadata.org. Data version October 2023.
Newly diagnosed with
Immune-mediated thrombotic thrombocytopenic purpura?
Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.
Advocacy Organizations
Help Hope Live
Help Hope Live assists individuals living with catastrophic injuries and illnesses to fundraise toward their medical expenses and related costs.
Care-for-Rare America Inc
To establish a global alliance in order to identify the genetic causes of rare diseases and develop effective treatments, following a three-stage approach: recognize, understand, cure.
Youth and Women for Opportunities Uganda-YWOU
Youth and Women for Opportunities-YWOU an organization that we represent is patient organization re-presentative, patient and institution and individual capacity builder supporting PLWRD’s to obtain diagnosis, treatment and drugs for those suffering consequences of being undiagnosed or misdiagnosed and lack treatment and those who lack precise diagnosis for rare, orphan and undiagnosed diseases preventing PLWRD’s accessing the most adapted care, treatment or surgery, have delayed access to the most appropriate care, treatment or surgery
Clinical Trials
For a list of clinical trials in this disease area, please click here.